A gonadotropin-releasing hormone agonist versus a continuous oral contraceptive pill in the treatment of bladder endometriosis

Fertil Steril. 2008 Jul;90(1):183-4. doi: 10.1016/j.fertnstert.2007.09.060. Epub 2008 Jan 4.

Abstract

A prospective comparative clinical trial was done in a tertiary referral center for the treatment of endometriosis in 10 patients with bladder detrusor endometriosis: five were treated with a continuous oral contraceptive (OC) and another five with a GnRH agonist. Continuous OC therapy may be effective in the short-term treatment of bladder endometriosis.

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Contraceptives, Oral / therapeutic use*
  • Endometriosis / drug therapy*
  • Endometriosis / pathology
  • Female
  • Gonadotropin-Releasing Hormone / agonists*
  • Humans
  • Prospective Studies
  • Time Factors
  • Treatment Outcome
  • Urinary Bladder / drug effects*
  • Urinary Bladder / pathology
  • Urinary Bladder Diseases / drug therapy*
  • Urinary Bladder Diseases / pathology

Substances

  • Contraceptives, Oral
  • Gonadotropin-Releasing Hormone